Publications

5491 Results

Nivolumab-AVD is better tolerated and improves progression-free survival compared to Bv-AVD in older patients (aged =60 years) enrolled on SWOG S1826

Authors
S Rutherford;H Li;A Herrera;M LeBlanc;S Ahmed;K Davison;C Casulo;N Bartlett;J Tuscano;B Hess;P Torka;P Kumar;R Jacobs;J Song;S Castellino;B Kahl;J Leonard;S Smith;JW Friedberg;A Evens
Journal / Conference
ASH Annual Meeting (Dec9-12,2023, San Diego, CA), oral
Year
2023
Research Committee(s)
Lymphoma
Study Number(s)
S1826

Novel Approach to Accelerate Lung Cancer Research: LungMap and the Potential of Public-Private Partnerships

Authors
RS Herbst;CD Blanke;E Sigal
Journal / Conference
Clinical Cancer Research Oct 30. doi: 10.1158/1078-0432.CCR-23-2690. Online ahead of print
Year
2023
Research Committee(s)
Lung
PMID
PMID37903180
Study Number(s)
LUNGMAP

Ibrutinib Added to Standard Conditioning and As Consolidation Therapy Following Autologous Hematopoietic Stem Cell Transplantation (AutoHCT) for Relapsed/Refractory Activated-B-Cell Subtype Diffuse Large B-Cell Lymphoma (ABC-DLBCL): Primary Analysis of the US Intergroup Double-Blind Randomized Phase III Study Alliance A051301/BMT-CTN 1201

Authors
C Andreadis;O Bobek;E Hsi;T Fenske;S Geyer;P Stiff;B Till;M Horwitz;F Khimani;R Little;S Dinner;J Friedberg;B Kahl;M Perales;S Devine;J Leonard;N Bartlett
Journal / Conference
ASH Annual Meeting (Dec9-12,2023, San Diego, CA), oral
Year
2023
Research Committee(s)
Lymphoma
Study Number(s)
CTSU/A051301

Single Cell Transcriptomic Analysis of B-Cell Acute Lymphoblastic Leukemia (B-ALL) Reveals Correlation between Leukemia Cell State, Genetic Alterations and Clinical Outcome

Authors
I Iacobucci;A Zeng;Q Gao;L Garcia Pratt;P Baviskar;S Shah;A Murison;V Voisin;C Bailey;M Lear;A Advani;S Luger;E Paietta;W Stock;J Dick;C Mullighan
Journal / Conference
ASH Annual Meeting (Dec9-12,2023, San Diego, CA), oral
Year
2023
Research Committee(s)
Leukemia

Assessment of Outcomes of Consolidation Therapy By Number of Cycles of Blinatumomab Received in Newly Diagnosed Measurable Residual Disease Negative Patients with B-Lineage Acute Lymphoblastic Leukemia: In the ECOG-ACRIN E1910 Randomized Phase III National Clinical Trials Network Trial

Authors
S Luger;X Sun;R Mattison;E Paietta;K Roberts;Y Zhang;J Racevckis;H Lazarus;J Rowe;D Arber;M Wieduwilt;M Liedtke;J Bergeron;B Wood;Y Zhao;G Wu;T Chang;W Zhang;K Pratz;S Dinner;N Frey;S Gore;B Bhatnagar;E Atallah;G Uy;D Jeyakumar;T Lin;C Willman;D DeAngelo;E Sharon;R Little;H Erba;R Stone;C Mullighan;M Litzow;M Tallman
Journal / Conference
ASH Annual Meeting (Dec9-12,2023, San Diego, CA), poster
Year
2023
Research Committee(s)
Leukemia
Study Number(s)
CTSU/E1910

Phase II Study of Palbociclib (PD-0332991) in CCND1, 2, or 3 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1B

Authors
A Clark;F Hong;R Finn;A DeMichelle;E Mitchell;J Ziebel;F Arnaldez;F Arnaldez;R Gray;V Wang;L McShane;L Rubinstein;D Patton;P Willams;S Hamilton;M Copur;S Kasbari;R Thind;B Conley;C Arteaga;P O'Dwyer;L Harris;A Chen;K Flaherty
Journal / Conference
Clin Cancer Res 14;29(8):1477-1483
Year
2023
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
PMID36853016
PMC
PMC10102836
Study Number(s)
CTSU/EAY131

Surgical outcomes of SWOG S1801: Neoadjuvant versus adjuvant pembrolizumab for resectable stage III-IV melanoma

Authors
M Lowe;M Othus;J Hyngstrom;G Paul Wright;E Sharon;A Ribas;SP Patel;V Sondak
Journal / Conference
Society of Surgical Oncology (March 22-25, 2023, Boston, MA), oral plenary
Year
2023
Research Committee(s)
Melanoma
Study Number(s)
S1801

Neoadjuvant Pembrolizumab in Stage II-III Desmoplastic Melanoma (SWOG S1512): Surgical Considerations

Authors
V Sondak;S Bellasea;J Hyngstrom;C Contreras;A Terando;M Monroe;M Harrington;D Wada;J Plaza;Z Eroglu;S Hu-Lieskovan;G In;A Ikeguchi;E Sharon;M Wu;J Moon;A Ribas;S Patel;W Carson;K Kendra
Journal / Conference
Society of Surgical Oncology (March 22-25, 2023, Boston, MA), oral
Year
2023
Research Committee(s)
Melanoma
Study Number(s)
S1512

Quality Metrics in an NCTN Network Group

Authors
P Goodman;C Rankin
Journal / Conference
Society for Clinical Trials (May 21-24, 2023, Baltimore, MD), poster
Year
2023
Research Committee(s)
Cancer Care Delivery

Beyond Static Tables and Figures: Utilizing Technology to Make Tables and Figures Richer and More Interactive

Authors
C Cook;K Snappin;D Law;A Hoering;M LeBlanc
Journal / Conference
Society for Clinical Trials (May 21-24, 2023, Baltimore, MD), poster
Year
2023
Research Committee(s)
Cancer Care Delivery